JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BARNES, C. A.
Right arrow Articles by DUNCAN, G. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BARNES, C. A.
Right arrow Articles by DUNCAN, G. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 72, Issue 3, 331-343, 1941
Copyright © 1941 by American Society for Pharmacology and Experimental Therapeutics


HISTONE ZINC INSULIN—ITS PHARMACOLOGIC CHARACTERISTICS AND ITS APPLICATION IN THE TREATMENT OF DIABETES MELLITUS

CHARLES A. BARNES 1, TRACY D. CUTTLE 1, and GARFIELD G. DUNCAN 1

1 From the Medical Service, Pennsylvania Hospital, Philadelphia

The comparative effects of identical doses of histone zinc, unmodified, crystalline, and protamine zinc insulin were observed under strictly controlled conditions in twelve diabetic patients and in one nondiabetic subject. The hypoglycemic effects of unmodified and crystalline insulin disappeared between six and eight hours after administration, whereas those of histone zinc insulin subsided in eighteen to twenty-two hours, and those of protamine zinc insulin between twenty-four and thirty-six hours.

The blood sugar lowering effect of histone zinc insulin is less abrupt and more prolonged than that of unmodified and crystalline insulin but more prompt than that of protamine zinc insulin. These qualities make it possible

[See table in the PDF file]

to secure a continuously normal blood sugar level and a freedom from glycosuria in a larger number of patients after a single morning injection of histone zinc insulin than is possible when other preparations are employed.

Submitted on January 14, 1941







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1941 by the American Society for Pharmacology and Experimental Therapeutics.